Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis.
Nonandrogenic hormones are implicated in the growth and function of the prostate, which is itself an endocrine gland that synthesizes and secretes hormones and growth factors, including follicle-stimulating hormone (FSH) and prostatic inhibin peptide (PIP). Findings of increased FSH concentrations and receptor expression in diseased prostate tissue suggest a role for FSH in prostate cancer growth. Not only does PIP suppress circulating levels of FSH, but it responds to and modulates prostatic FSH, suggesting a close interlinkage of these compounds in controlling both healthy and diseased prostate cells. Other focuses of endocrinologic research include androgen receptors, vitamin D, growth factors (including insulin-like growth factors I and II), and retinoids. Issues such as optimal therapy timing, intermittent administration, and the adoption of a multihormonal approach to the management of prostate cancer remain to be resolved.
Porter
A
A
Department of Radiation Oncology, Wayne State University, Detroit, Michigan, USA. ceo@dmc.org
Ben-Josef
E
E
Crawford
E D
ED
Garde
S
S
Huhtaniemi
I
I
Pontes
J E
JE
D005640:Follicle Stimulating Hormone / Q000502:physiology; D006728:Hormones / Q000502:physiology*; D006801:Humans; D007986:Luteinizing Hormone / Q000502:physiology; D008297:Male; D011471:Prostatic Neoplasms / Q000209:etiology* / Q000628:therapy; D029584:Prostatic Secretory Proteins / Q000502:physiology; D011944:Receptors, Androgen; D012106:Research
D006728:Hormones; D029584:Prostatic Secretory Proteins; D011944:Receptors, Androgen; C043076:beta-microseminoprotein; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone